English

This Special Report from Medecins Sans Frontieres/Doctors Without Borders highlights the challenges, such as TB/HIV coinfection and drug resistance, faced in the fight against TB. The report also provides real-life examples of people living with TB.

This fact sheet explains the facts about DOT.

This fact sheet discusses the meaning of a negative TB skin test and states that persons with HIV/AIDS may be at risk for false negative results.

This report examines how children become infected with HIV, how infection can be prevented in children, and ways of reducing the impact of HIV. The report discusses statistics and data concerning pediatric HIV/AIDS, transmission; prevention, including health education and prevention of HIV in women of childbearing age and of unintended pregnancies in HIV-positive women and women at risk; and treatment.

This report provides preliminary information about 21 cases of liver injury associated with rifampin-pyrazinamide (RIF-PZA) and the revised recommendations on selecting appropriate therapy for patients with latent TB infection and monitoring the use of RIF-PZA to treat infection.

This report describes the results of the investigation of a cluster of TB cases that occurred in Kansas from 1994 to 2000 among women with a history of working as exotic dancers and persons who were close contacts of the dancers.

This announcement gives a brief overview of World TB Day, which recognizes the collaborative efforts of all countries involved in eliminating TB.

This report discusses two cases of latent TB infection in which patients developed severe or fatal hepatitis associated with rifampin-pyrazinamide (RIF-PZA) treatment.

This report updates previous US Public Health Service recommendations for the management of health-care personnel (HCP) who have occupational exposure to blood and other body fluids that may contain Hepatitis B, Hepatitis C, or HIV/AIDS. It contains recommendations for Hepatitis B Virus postexposure management including initiation of hepatitis B vaccine series to any susceptible, unvaccinated person who sustains blood or body fluid exposure. Guidance is provided to clinicians and exposed HCP for selecting the appropriate HBV postexposure prophylaxis (PEP).

This MMWR provides revised guidelines for HIV counseling, testing, and referral (CTR) and revised recommendations for HIV screening of pregnant women. It encourages the availability of anonymous and confidential HIV testing and informed, voluntary, and consented HIV testing; access to testing and effective provision of test results; and using a prevention counseling approach aimed at personal risk reduction for HIV-infected persons and persons at increased risk for HIV infection.